Patents by Inventor Donald Colin Mackenzie

Donald Colin Mackenzie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
    Patent number: 9717703
    Abstract: Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: August 1, 2017
    Assignee: GLAXOSMITHKLINE LLC
    Inventors: Omar Abdelfattah Abu-Baker, Donald Colin MacKenzie, Rennan Pan
  • Composition and use
    Patent number: 8236345
    Abstract: A pharmaceutical composition, comprising a thiazolidinedione, such as Compound (I), metformin hydrochloride and a pharmaceutically acceptable carrier, wherein the thiazolidinedione and metformin hydrochloride are each dispersed within its own pharmaceutically acceptable carrier in the pharmaceutical composition and the use of such a composition in medicine.
    Type: Grant
    Filed: July 18, 2007
    Date of Patent: August 7, 2012
    Assignee: SmithKline Beecham Limited
    Inventors: Karen Lewis, Nicola Jayne Lilliott, Donald Colin MacKenzie
  • Novel Composition Comprising Rosiglitazone and Another Antidiabetic Agent
    Publication number: 20080206336
    Abstract: An oral dosage form comprising an erodable core, which core comprises Compound A or a pharmaceutically acceptable salt or solvate thereof and another antidiabetic agent, the core having a coating with one or more openings, characterised in that the coating is erodable under predetermined pH conditions; a process for preparing such a dosage form and the use of such a dosage form in medicine.
    Type: Application
    Filed: August 9, 2004
    Publication date: August 28, 2008
    Applicant: SB PHARMCO PURERTO RICO INC. The Prentice Hall Corp. System of P.R. Inc.
    Inventors: Peter John Coles, Donald Colin Mackenzie, Paul Norman Mudd
  • Tartrate salts of thiazolidinedione derivative
    Publication number: 20040087629
    Abstract: A novel pharmaceutical compound 5-[4-2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione L(+) Tartrate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: July 16, 2003
    Publication date: May 6, 2004
    Inventors: Berndette Marie Choudary, Andrew Simon Craig, Tim Chien Ting Ho, Donald Colin Mackenzie, Deirdre O'Keeffe
  • Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
    Publication number: 20040081697
    Abstract: A pharmaceutical composition, which composition comprises: an insulin sensitiser and another antidiabetic agent and a pharmaceutically acceptable carrier therefor, wherein the composition is arranged to provide a modified release of at least one of the insulin sensitiser and the other antidiabetes agent, and the use of such composition in medicine.
    Type: Application
    Filed: October 21, 2003
    Publication date: April 29, 2004
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Karen Lewis, Nicola Jayne Lilliott, Donald Colin MacKenzie, Vincenzo Re
  • Tartrate salts of thiazollidnedione derivative
    Publication number: 20040048899
    Abstract: A novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino) ethoxy]benzyl]thiazolidine-2,4-dione D(−) Tartrate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine
    Type: Application
    Filed: July 30, 2003
    Publication date: March 11, 2004
    Inventors: Bernadette Marie Choudary, Andrew Simon Craig, Tim Chien Ting Ho, Donald Colin Mackenzie, Deirdre O'Keeffe
  • Substituted thiazolidinedione derivatives
    Patent number: RE39384
    Abstract: A compound of formula (I): or a tautomeric form thereof, wherein: R1 represents a hydrogen atom, C1-12 alkyl, C1-12 alkoxy, C1-12 alkylcarbonyl or arylC1-12 alkyl; A1 represents hydrogen or 1 to 4 optional substituents selected from the group consisting of: C1-12 alkyl, C1-12 alkoxy, aryl, and halogen; aryl represents phenyl or naphthyl optionally substituted with up to five groups selected from halogen, C1-12 alkyl, phenyl, C1-12 alkoxy, haloC1-12 alkyl, hydroxy, nitro, C1-12 alkoxycarbonyl, C1-12 alkoxycarbonyl C1-12 alkyl, C1-12 alkoxycarbonyloxy, or C1-12 alkylcarbonyl: A2 represents a benzene ring having 1 to 3 optional substituents selected from hydrogen, halogen, C1-12 alkyl, C1-12 alkoxy; and M? represents a counter-ion other than the maleate ion.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: November 7, 2006
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Philip Christopher Buxton, Donald Colin Mackenzie